Back to top

Research Daily

Mark Vickery

Top Research Reports for Bank of America, Toyota Motor & Shell

BAC GD CME BSX TM UUU SHEL

Trades from $3

Monday, February 9, 2026

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Bank of America Corp. (BAC), Toyota Motor Corp. (TM) and Shell plc (SHEL), as well as a micro-cap stock Universal Safety Products, Inc (UUU). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.

These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Ahead of Wall Street

The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.

You can read today's AWS here >>> Big Week for Economic News, Q4 Earnings Reports

Today's Featured Research Reports

Bank of America’s shares have outperformed the Zacks Financial - Investment Bank industry over the past six months (+23.7% vs. +17.2%). The company’s earnings outpaced the Zacks Consensus Estimate in each of the trailing four quarters. Its fourth-quarter 2025 results were aided by higher revenues, partly offset by a rise in costs. 

Despite the rate cuts, the company's net interest income (NII) is expected to be aided by loan growth and lower funding costs. The company’s plans to open financial centers in new and existing markets, and improve digital capabilities will likely support the top line. 

Yet, the volatile nature of the capital markets makes growth in trading revenues uncertain. Despite a robust trading performance since 2022, growth may normalize going forward. Elevated expenses due to steady investments in franchise will likely hurt bottom-line growth. Weak asset quality is another concern.

(You can read the full research report on Bank of America here >>>)

Shares of Toyota Motor have outperformed the Zacks Automotive - Foreign industry over the past six months (+27.9% vs. +14.9%). The company is witnessing a surge in hybrid adoption which is boosting its sales. Toyota Motor plans to significantly expand hybrid and plug-in hybrid production by 2028. Upbeat outlook for fiscal 2026 sales sparks optimism. 

Higher expected year-over-year sales are likely to boost the company’s top-line growth in fiscal 2026. Toyota is taking initiatives to improve profits by lowering the level of sales needed to break even.

However, material prices, forex rate and tariffs imposed by the U.S. government on vehicle and vehicle parts imports are expected to be a big hit on the operating profits in fiscal 2026. High R&D expenses on advanced technologies and alternative fuels for the development of electric and autonomous vehicles are likely to limit the near-term margins. As such, the stock warrants a neutral stance.

(You can read the full research report on Toyota Motor here >>>)

Shell’s shares have gained +9.8% over the past six months against the Zacks Oil and Gas - Integrated - International industry’s gain of +30%. The company being a London based oil supermajor, looks fairly balanced at the moment. Shell demonstrated resilient cash generation in 2025, delivering robust operating and free cash flows, supporting shareholder returns. 

Shell’s LNG franchise remains a long-term strength, with solid sales growth and clear demand visibility. Structural cost reductions achieved ahead of schedule and portfolio simplification have improved efficiency and balance-sheet flexibility. 

However, earnings and revenue declined year over year, highlighting exposure to commodity price cycles. Net debt increased, while Chemicals and Renewables continue to weigh on returns amid weak margins. Potential LNG oversupply and geopolitical volatility add uncertainty. Overall, strengths are offset by cyclical and segment-specific risks, justifying a neutral stance.

(You can read the full research report on Shell here >>>)

Shares of Universal Safety Products have outperformed the Zacks Building Products - Miscellaneous industry over the past six months (+77.5% vs. +11.3%). This microcap company with a market capitalization of $10.18 million has materially strengthened its balance sheet following the May 2025 divestiture of its core operating assets. Cash increased to $5.2 million, and factoring debt was fully eliminated, reducing near-term financial risk and improving flexibility during its transition. 

Management demonstrated disciplined capital allocation by returning $2.3 million to shareholders via a $1.00 special dividend. Liquidity was extended through $2.5 million of convertible financing, supporting operations into late 2026. 

Yet, the divestiture drove a sharp revenue contraction, leaving the company without a stable operating base as it explores a new direction. Elevated SG&A, customer concentration, tariff sensitivity, potential dilution and internal control weaknesses weigh on earnings quality and valuation. The valuation reflects both balance-sheet improvement and execution risk.

(You can read the full research report on Universal Safety Products here >>>)

Other noteworthy reports we are featuring today include Boston Scientific Corp. (BSX), CME Group Inc. (CME) and General Dynamics Corp. (GD).

Mark Vickery
Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Featured Reports

New Upgrades

New Downgrades

Zacks' 7 Best Strong Buy Stocks (New Research Report)

Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.

Click Here, It's Really Free